Prelude Therapeutics Inc (NAS:PRLD)
$ 3.9 0 (0%) Market Cap: 214.22 Mil Enterprise Value: 29.94 Mil PE Ratio: 0 PB Ratio: 1.02 GF Score: 38/100

Prelude Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 09:00PM GMT
Release Date Price: $44.3 (+7.58%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Okay, everybody, good afternoon. Thanks for sticking around to see our afternoon sessions of the BofA Healthcare Conference.

It's my pleasure to have my next presenting company, Prelude. Presenting for Prelude today are several members of the management team, including Kris Vaddi, Christopher Pierce, as well as Brian Piper. Gentlemen, good afternoon. Thank you so much for joining us.

Brian D. Piper
Prelude Therapeutics Incorporated - CFO

Good afternoon, Tazeen. Thanks for having us.

Christopher Pierce
Prelude Therapeutics Incorporated - Executive VP & Chief of Business Operations

Thanks very much, Tazeen.

Krishna Vaddi
Prelude Therapeutics Incorporated - Founder, CEO & Director

Thank you, and good afternoon, and thanks for the opportunity to participate in the conference.

Tazeen Ahmad
BofA Securities, Research Division - VP

Of course, so Kris, maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot